Skip to main content
VERO
NASDAQ Industrial Applications And Services

Venus Concept to Voluntarily Delist from Nasdaq and Deregister with SEC Amidst Ongoing Financial Challenges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$5.25
Mkt Cap
$8.273M
52W Low
$1.39
52W High
$14.5
52W Position info
278% above low
Off High info
64% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

VERO has more than doubled off its 52-week low of $1.39.

Summary

Venus Concept Inc. announced its decision to voluntarily delist from Nasdaq and deregister with the SEC, citing cost savings and low trading volumes, while also securing a 17-day extension on a bridge loan and liquidity waivers.


Key Events · Corporate Governance and Compliance · VERO

  • Voluntary Delisting from Nasdaq

    The company's Board approved a plan to delist its common stock from the Nasdaq Capital Market and deregister with the SEC, with trading expected to cease around February 6, 2026.

  • Cessation of SEC Reporting

    Following delisting, the company intends to suspend its obligation to file periodic reports (10-K, 10-Q, 8-K) with the SEC, significantly reducing public transparency.

  • Bridge Loan Extended for 17 Days

    The company secured a 24th amendment to its Bridge Loan, extending the maturity date from January 14, 2026, to January 31, 2026, indicating ongoing short-term financial challenges.

  • Liquidity Requirements Waived

    Lenders granted waivers for certain minimum liquidity requirements under both the MSLP Loan Agreement and the Bridge Loan through January 31, 2026, further highlighting financial strain.


Analysis · VERO · Industrial Applications And Services

The decision by Venus Concept to voluntarily delist from Nasdaq and deregister with the SEC is a highly significant negative event for shareholders. While the company states the move is for cost savings and to focus on long-term value, it effectively removes public market liquidity and transparency, often signaling severe financial distress or an inability to meet the demands of being a public company. This action is further underscored by the simultaneous announcement of a 24th amendment to a bridge loan, extending its maturity by only 17 days, and waivers of minimum liquidity requirements. These short-term financial maneuvers highlight the company's precarious financial position and limited operational runway. Investors should be aware of the impending loss of trading on a major exchange and the cessation of regular SEC filings, which will significantly reduce available information and ease of trading.

At the time of this filing, VERO was trading at $5.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $1.39 to $14.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VERO - Latest Insights

VERO
Mar 30, 2026, 9:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
10
Price at Filing: $0.3074
Real-time Price: $0.31051 info
Change: Low Volume info
Market Cap: $577.275K info
VERO
Mar 30, 2026, 9:16 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.3074
Real-time Price: $0.31051 info
Change: Low Volume info
Market Cap: $577.275K info
VERO
Mar 27, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.3374
Real-time Price: $0.31051 info
Change: Low Volume info
Market Cap: $577.275K info
VERO
Mar 27, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.3374
Real-time Price: $0.31051 info
Change: Low Volume info
Market Cap: $577.275K info
VERO
Mar 18, 2026, 5:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.310
Real-time Price: $0.31051 info
Change: Low Volume info
Market Cap: $577.275K info